# Editas Medicine (EDIT) — Overview

EDIT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/edit

## Price

Last close $2.44 on Oct 15, 2026. 52-week range $1.67 – $4.14.

## Company profile

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $47.0M |
| Revenue (quarter) | $11.9M |
| Revenue growth (year over year) | 232.31% |
| Gross profit (trailing twelve months) | $47.0M |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$73.9M |
| Net income (quarter) | −$18.2M |
| Net income growth (year over year) | 65.76% |
| Net margin | -157.32% |
| Return on equity | -118.82% |
| EPS (trailing twelve months) | −$0.66 |
| Book value per share | $0.69 |
| P/E (trailing twelve months) | — |
| Price to book | 3.6 |
| Debt to assets | 55.65% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Editas Medicine (EDIT) profitable?

No. Editas Medicine reported a net loss of $73.9M over the trailing twelve months.

### How much revenue does Editas Medicine (EDIT) make?

Editas Medicine generated $47.0M in revenue over the trailing twelve months, up 232.31% year over year.

### How do I buy stock in Editas Medicine (EDIT)?

EDIT trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

## Similar Stocks

- [CRSP](https://www.lighthorse.io/tickers/crsp) — CRISPR Therapeutics AG - Common Shares
- [NTLA](https://www.lighthorse.io/tickers/ntla) — Intellia Therapeutics, Inc. - Common Stock
- [BEAM](https://www.lighthorse.io/tickers/beam) — Beam Therapeutics Inc. - Common Stock

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).